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Abstract
Genome-wide association studies (GWAS) have identified loci reproducibly associated with pulmonary diseases; however,
the molecular mechanism underlying these associations are largely unknown. The objectives of this study were to discover
genetic variants affecting gene expression in human lung tissue, to refine susceptibility loci for asthma identified in GWAS
studies, and to use the genetics of gene expression and network analyses to find key molecular drivers of asthma. We
performed a genome-wide search for expression quantitative trait loci (eQTL) in 1,111 human lung samples. The lung eQTL
dataset was then used to inform asthma genetic studies reported in the literature. The top ranked lung eQTLs were
integrated with the GWAS on asthma reported by the GABRIEL consortium to generate a Bayesian gene expression network
for discovery of novel molecular pathways underpinning asthma. We detected 17,178 cis- and 593 trans- lung eQTLs, which
can be used to explore the functional consequences of loci associated with lung diseases and traits. Some strong eQTLs are
also asthma susceptibility loci. For example, rs3859192 on chr17q21 is robustly associated with the mRNA levels of GSDMA
(P= 3.556102151). The genetic-gene expression network identified the SOCS3 pathway as one of the key drivers of asthma.
The eQTLs and gene networks identified in this study are powerful tools for elucidating the causal mechanisms underlying
pulmonary disease. This data resource offers much-needed support to pinpoint the causal genes and characterize the
molecular function of gene variants associated with lung diseases.
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Introduction
Recent genome-wide association studies (GWAS) have identi-
fied loci that harbor susceptibility genes for asthma and other
pulmonary conditions [1–16]. Many of the genes at these loci have
unknown function and have not previously been considered
biologically plausible candidates for disease pathogenesis. Exten-
sive linkage disequilibrium (LD) within these loci makes it difficult
to identify the actual susceptibility genes, let alone which genetic
variants are responsible for altered expression or function of their
protein products. Moreover, the associated polymorphisms can
only explain a relatively small proportion of the variability of the
phenotype in the population [9] and of its heritability [17].
Integrative genomics is a promising new approach to identify
true causal genes and variants. By using gene expression as a
phenotype and examining how DNA polymorphisms contribute
to both gene expression (expression quantitative trait loci –
eQTLs) and disease phenotype, true causal relationships can be
discovered [18–20]. In the present study we performed genome-
wide genotyping and lung-specific gene expression on a large
dataset of lung tissue (1,111 human subjects) to explore effects of
genetic variation on gene expression and their joint relationship
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to asthma. Although the lung tissue came from a heterogeneous
group of subjects, the discovery of lung tissue eSNPs could
elucidate the causal molecular pathways in a variety of
pulmonary disorders.
Results
Demographic characteristics of study participants
Demographic and clinical data for the 1,111 patients who
passed clinical, genotyping and gene expression quality control
assessments are summarized in Table 1 according to the three sites
of recruitment, Laval University, University of British Columbia,
and University of Groningen (henceforth referred to as Laval,
UBC, and Groningen, respectively). The majority of the subjects
were smokers or former-smokers. There were some differences in
the clinical characteristics across the sites including age, lung
function and smoking status. To account for this heterogeneity
between sites, we performed a meta-analysis rather than a pooled
analysis for eQTL discovery. The overall analysis workflow is
illustrated in Figure 1.
Genome-wide association analysis for expression traits
(eQTL)
We identified cis- and trans-acting eQTLs using established
methods [19]. For simplicity we assumed that each transcript
could have at most one cis-eQTL. We considered all association
signals from SNPs within 1 Mb up and downstream, of the
transcription probeset as a single cis-eQTL. Trans-eQTLs were
defined as association signals from SNPs located greater than
1 Mb from the probeset. The eSNP was identified as the SNP that
was most significantly associated (lowest P value) with the
expression trait. A summary of the eQTLs identified at 10% false
discovery rate (FDR) in the three cohorts as well as the meta-
analysis are reported in Table 2. There were variations in the
numbers of eQTLs across the cohorts. For example, we identified
10,630, 5,655 and 7,953 cis-eQTLs in the Laval, Groningen and
UBC cohorts, respectively. There were also variations in the
number of detectable trans-eQTLs (Table 2). The P values
reported for the trans-eQTLs are lower than those for cis-eQTLs,
owing to the higher statistical threshold required to achieve
statistical significance. In general, a single SNP (eQTL peak)
explained between 10 and 20% of the transcript’s expression
variance for cis- and trans-eQTLs, respectively (Table S1).
However 6.8% of the cis acting SNPs explained more than 30%
of the variance in the transcript and 15.3% of the trans acting SNPs
explained more than 30% of a transcript’s variance (Figure S1).
Further, we investigated the consistency of the eQTLs derived
from the cohorts. Rather than simply comparing the existence of
eQTLs, we adopted replication criteria similar to GWAS. A
successful replication was defined as an eQTL in which the
relationship between the same SNP and gene expression (with the
same sign) was observed in more than one cohort at a P of#161024.
Using this criterion, 54.5% of the Laval cis-eQTLs were replicated in
at least one other cohort and 79.5% of the Laval trans-eQTLs were
replicated in another cohort. With respect to the Groningen eQTLs,
the replication rates of the cis- and trans-eQTLs were 72.3% and
86.0%, respectively. The replication rates of the UBC cis- and trans-
eQTLs were 65.4% and 90.5%, respectively. The eQTLs with higher
R2values (variance of gene expression level explained) were more
likely to be replicated than those with lower R2 values. There was a
higher replication rate with trans-eQTLs than with cis-eQTLs.
The meta-analysis revealed many more eQTLs owing to the
increased sample size (Table 2). We identified 17,049 cis-eQTLs
and 534 trans-eQTL and the details of all eQTLs are listed in
Table S2. 68.7% of these cis-eQTLs and 31.7% of trans-eQTLs
were identified in at least one cohort, suggesting that the meta-
analysis detected many additional eQTLs. The ‘non-combinabil-
ity’ among cohorts is quantified in terms of Cochran’s Q and the t
statistics (Table S2). Cochran’s Q, was calculated as the weighted
sum of squared differences among individual study effects and the
pooled effect across studies, with the weights proportional to the
inverse of variance of the eQTL effect. Q follows a chi-square
statistic with k-1 degrees of freedom (k is the number of studies),
and by these means, we calibrated the p value (termed Q.pvalue).
We detected modest degrees of heterogeneity among the three
cohorts. 16% of the QTLs had Q.pvalue,0.05 and 2% of the
Author Summary
Recent genome-wide association studies (GWAS) have
identified genetic variants associated with lung diseases.
The challenge now is to find the causal genes in GWAS–
nominated chromosomal regions and to characterize the
molecular function of disease-associated genetic variants.
In this paper, we describe an international effort to
systematically capture the genetic architecture of gene
expression regulation in human lung. By studying lung
specimens from 1,111 individuals of European ancestry, we
found a large number of genetic variants affecting gene
expression in the lung, or lung expression quantitative trait
loci (eQTL). These lung eQTLs will serve as an important
resource to aid in the understanding of the molecular
underpinnings of lung biology and its disruption in
disease. To demonstrate the utility of this lung eQTL
dataset, we integrated our data with previous genetic
studies on asthma. Through integrative techniques, we
identified causal variants and genes in GWAS–nominated
loci and found key molecular drivers for asthma. We feel
that sharing our lung eQTLs dataset with the scientific
community will leverage the impact of previous large-scale
GWAS on lung diseases and function by providing much
needed functional information to understand the molec-
ular changes introduced by the susceptibility genetic
variants.








Quantitative traits, mean 6 SD
Age (years) * 63.3610.0 51.8615.2 60.0614.3
PreBD FEV1 % predicted * 80.5618.9 60.5630.0 80.4622.4
PreBD FVC % predicted * 89.8616.1 75.0626.5 88.9619.7
Categorical traits, %
Male 56.0 53.6 53.4
Smoking Status *
Non-smoker 8.7 28.6 8.8
Ex-smoker 69.0 54.9 56.8
Current-smoker 22.2 16.5 34.4
PreBD, before bronchodilator use; FEV1, forced expiratory volume in one
second; FVC, forced vital capacity.
*significantly different among groups at p,0.01 level (Kruskal Wallis and x2
tests were applied to quantitative and categorical traits, respectively).
doi:10.1371/journal.pgen.1003029.t001
Genetics of Lung Gene Expression
PLOS Genetics | www.plosgenetics.org 2 November 2012 | Volume 8 | Issue 11 | e1003029
eQTLs showed Q.pvalue,0.001. We also present the t statistic,
which is the moment-based estimate of the between-study variance
and is not dependent on the number of studies. Both the fixed
effect and random effect meta-analysis results are presented in
Table S2, and we used the fix effect results in the downstream
analysis. We previously showed that the number of eQTLs
detectable at a certain FDR was related directly to the sample size
(i.e. statistical power) [21]. The meta-analysis yielded a greater
relative increase in the number of trans activating eQTLs than of
cis-eQTLs, suggesting that sample size is particularly important for
detecting trans-eQTLs. Among the 51,627 non-control probesets
on our array, 33.0% showed a cis-eQTL. 74.0%, 64.4%, 56.4% of
the 51,627 probesets were ‘‘present’’ in at least 20%, 50%, and
80% of the tissue samples. Using these three cutoffs, 40.2%,
42.5%, and 43.4% of the ‘‘present’’ transcripts were found to be
controlled by cis-eSNPs, respectively. Accordingly we believe that
we have identified the majority of the strong lung cis-eQTLs.
As reported previously [22,23], eQTLs were often found with the
expression of more than one gene underlying a GWAS signal
(Table 3). For example, the rs7216389-T allele on chromosome 17q
was reported to increase asthma risk with an odds ratio (OR) of 1.45
[10]. This SNP was significantly associated with the expression
levels of four genes, ORMDL3, GSDMA, GSDMB, and CRKRS
(Figure 2a). Although ORMDL3 was originally suggested [10] to be
the gene mediating rs7216389-T’s association with asthma, this
gene demonstrated the weakest eQTL signal of the four genes in our
dataset. Rs7216389-T was positively associated with expression
levels of ORMDL3 (P=161027), CRKRS (P=1.7661029) and
GSDMB (P=4610215), consistent with the results of Moffat et al.
[10] However, this same allele was inversely related to the level of
expression of GSDMA (P=8.78610225) (Figure 2b). The strongest
eSNP in the 17q asthma susceptibility locus was rs3859192 located
in intron 6 of the GSDMA gene governing the expression levels of
this gene (P=3.556102151) (Figure 2b).
To determine the cellular source and relative expression of
GSDMB and GSDMA in human lung we performed real-time
PCR, and Western blots on primary normal airway epithelial cells
and immunohistochemistry on formalin-fixed normal lung tissue
(see Text S1 for details). Figure 3 shows abundant mRNA and
protein expression of GSDMA but little GSDMB from primary
human lung epithelial cells (Figure 3a and 3b respectively).
Figure 3c shows that GSDMA is expressed in both apical and basal
airway epithelial cells in the conducting airways.
Table 2. Summary of expression QTLs detected at 10% false
discovery rate.
Laval Groningen UBC Meta-Analysis
cis-eQTL P value cutoff 4.0e205 2.3e205 2.8e205 5.9e205
trans-eQTL P value cutoff 4.9e210 1.2e210 1.6e210 7.0e210
number of cis-eQTLs 10,630 5,655 7,953 17,049
number of trans-eQTLs 130 96 108 534
doi:10.1371/journal.pgen.1003029.t002
Figure 1. Overall study design and analysis workflow.
doi:10.1371/journal.pgen.1003029.g001
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Table 3. Expression eQTL underlying Asthma GWAS hits.
SNP Gene Symbol ProbeSet eQTL b (P value) Meta P value
Laval Groningen UBC
rs7216389 Moffatt et al., Nature
C T* ORMDL3 100127152_TGI_at NA NA 0.30 (9.42E205) 1.29E206
GSDMA 100138145_TGI_at 20.43 (7.60E211) 20.41 (4.38E208) 20.42 (8.23E208) 8.78E225
GSDMB 100144966_TGI_at NA 0.39 (6.42E208) NA 4.15E214
CRKRS 100152237_TGI_at 20.35 (4.28E207) NA NA 2.02E209
CRKRS 100305614_TGI_at 20.35 (3.61E207) NA NA 2.79E209
CRKRS 100307813_TGI_at 20.31 (6.95E206) NA NA 1.76E209
rs2305480 Moffatt et al, NEJM
A G ORMDL3 100127152_TGI_at NA NA NA 2.11E205
GSDMA 100138145_TGI_at 0.48 (3.18E213) 0.44 (2.88E209) 0.50 (7.94E211) 7.43E232
GSDMB 100144966_TGI_at NA 20.36 (4.69E207) NA 2.52E212
CRKRS 100152237_TGI_at 0.29 (2.63E205) NA NA 4.45E207
CRKRS 100305614_TGI_at 0.28 (5.27E205) NA NA 3.77E207
CRKRS 100307813_TGI_at NA NA NA 4.28E207
rs3859192** Moffatt et al, NEJM
C T GSDMA 100138145_TGI_at 20.91 (1.96E268) 20.75(3.15E232) 20.90(1.20E254) 3.55E2151
GSDMB 100144966_TGI_at NA NA NA 3.86E25
rs2244012 Li et al., JACI
A G RAD50 100132153_TGI_at NA NA NA 5.62E206
rs9273349 Moffatt et al., NEJM
C T HLA-DRB 100125275_TGI_at NA NA 0.37 (1.17E206) 2.60E207
AGPAT1 100126665_TGI_at NA 0.47 (5.82E212) 0.53 (7.23E213) 1.06E224
AGPAT1 100135327_TGI_at NA 0.36 (3.76E207) 0.43 (1.05E208) 7.77E215
NA 100160430_TGI_at NA 20.48 (3.48E212) 20.51 (8.68E212) 6.78E224
HLA-DQB 100300398_TGI_at NA 0.57 (8.39E217) 0.55 (1.80E213) 2.70E231
HLA-DRB5 100302940_TGI_at NA 0.51 (3.48E213) 0.50 (1.23E211) 6.28E225
HLA-DQB 100302941_TGI_at NA 0.58 (4.51E217) 0.55 (1.76E213) 1.21E231
HLA-DQB 100304009_TGI_at NA 0.58 (3.76E217) 0.55 (1.23E213) 6.58E232
NA 100311684_TGI_at NA 0.37 (1.32E207) 0.35 (4.43E206) 1.05E212
HLA-DQB 100311704_TGI_at NA 0.62 (1.12E219) 0.72 (9.13E224) 2.58E247
HLA-DRB 100312946_TGI_at NA 0.34 (1.43E206) 0.49 (6.20E211) 2.22E216
HLA-DQA2 100313766_TGI_at NA 20.60 (1.93E218) 20.61 (1.43E216) 6.52E237
rs3894194 Moffatt et al., NEJM
G A GSDMA 100138145_TGI_at 20.75 (1.45E229) 20.65 (5.25E219) 20.67 (5.83E219) 2.76E273
GSDMB 100144966_TGI_at NA NA NA 1.57E207
CRKRS 100307813_TGI_at NA NA 20.32 (5.04E205) 1.51E205
rs1295686 Moffatt et al., NEJM
C T SLC22A5 100123073_TGI_at NA NA NA 3.49E205
rs13431828*** Moffatt et al., NEJM
IL1RL1 100148162_TGI_at 20.44 (1.96E25) NA NA 7.48E208
rs2073643 Moffatt et al., NEJM
T C SLC22A5 100123073_TGI_at 0.44 (1.12E210) 0.31 (7.13E206) 0.41 (1.69E208) 9.17E223
RAD50 100132153_TGI_at 0.32 (2.72E206) NA NA 4.44E211
CDC42SE2 100308155_TGI_at NA NA NA 1.04E205
rs2786098 Sleiman et al., NEJM
T G CRB1 100144551_TGI_at 20.35 (7.03E205) NA NA 1.08E208
*Beneath the SNP ID in column 1, the reference allele and risk allele are shown (e.g. for rs7216389, C is the reference allele and T the risk allele).
**Moffatt et al. [9] reported that rs3859192 in the 17q region was associated with asthma (P= 1.12610212). SNP rs3859192 was the most significant eSNP at this locus –
strongly associated with GSDMA levels (P= 3.556102151) but weakly associated with GSDMB levels (P=3.8661025).
Genetics of Lung Gene Expression
PLOS Genetics | www.plosgenetics.org 4 November 2012 | Volume 8 | Issue 11 | e1003029
While most GWAS publications only report the top signals, the
GABRIEL study [9] released the asthma association results on all
SNPs investigated, allowing an in-depth analysis. For this analysis,
we did not limit the list of eSNPs to the most significant SNP for
each probeset; all cis eSNPs which passed the 10% FDR for any
probe-set were considered. Using this strategy 60,530 of the
567,589 GABRIEL SNPs were eSNPs in lung tissue. These 60,530
eSNPs were enriched for significant association with asthma in the
GABRIEL study (Figure 4). This is consistent with previous studies
showing that SNPs associated with complex traits are more likely
to be eQTLs [24].
Key Driver Analyses (KDA) of networks
One of the drawbacks of GWAS is the reliance on a large
number of statistical tests, which puts the threshold for
significance at an extremely low level thereby increasing the chance
of missing real associations. Given that asthma is a pulmonary disorder
it is reasonable to assume that important molecular drivers are
expressed in lung tissue. Therefore, instead of filtering primarily by P
values to identify loci/genes that explain asthma, we filtered the loci in
the GABRIEL [9] dataset by their status as a cis acting eSNP.
Specifically, all SNPs from the GABRIEL study associated with
asthma with P,0.01 were translated into genes via our lung eSNP list.
A total of 7,613 SNPs were linked to the expression of 739 unique
genes.
Using Bayesian networks constructed on gene expression data
we attempted to find the molecular underpinnings of asthma. For
this discussion we define a Bayesian network as a probabilistic
graphical model that represents a set of random variables (gene
expression in this case) and their conditional dependencies (edges)
via a directed acyclic graph (see Text S1). The workflow is illustrated
in Figure S2. We first identified each gene from the GABRIEL
GWAS dataset and collected all genes within 3 edges of that gene on
the Bayesian Networks and found the largest coherent sub-network
(i.e. the largest network with an observable path between every gene
in the network) that contained the highest proportion of GABRIEL
genes (Figure S3). We choose to use 3 edges so that we had enough
genes to lead to a reasonable biological annotation of the genes in
the network, i.e. limiting to 2 edges is too restrictive and results in a
small number of relevant genes; on the other hand, using 4 edges
leads to broad gene sets and makes it hard to pinpoint pathways.
From this sub-network, we performed Key Driver Analyses (KDA)
to capture key regulators of asthma [25,26]. KDA is a method that
captures the ‘‘hub nodes’’ conditioning on the direction that one
gene influences over other genes and isolating those genes with the
strongest influence over the entire network. KDA determines the
regulatory components in a directed network for a particular set of
genes (i.e. the genes whose expression levels were control by
GABRIEL GWAS SNPs). With this analysis, we identified well
documented asthma candidate genes [27] that drive genes
discovered in GABRIEL. These genes are denoted as canonical
asthma genes. Figure 5 shows the top 6 key driver genes (yellow
nodes) that control the asthma canonical genes (blue nodes) as well
as other genes that are one edge away from the key driver genes
(grey nodes). The network when annotated with GeneGo intuitively
is described as ‘‘Immune Response’’ (the number of overlap genes is
25, from a 1,346 genes set, with the background being 16,606,
P=3.53610220). The KDA data in Table S3 shows the six genes
that remain significant after adjustments for multiple testing.
Network biology
Networks provide a means for data integration. Above we used
the networks to define a central node of the network that drives
asthma by integrating lung Bayesian networks, asthma GWAS and
literature (canonical genes) to arrive at set of genes that drive the
asthma genes in the lung Bayesian network. Similarly we can use
the Bayesian networks to rank competing genetic hypotheses
around the molecular basis of asthma. It has been shown that the
neighborhood milieu of proteins in a network can predict the
probable function of a protein for which no function is known
[28]. Following the same logic we assessed the sub-network
surrounding each candidate causal gene for asthma. The gene
with the highest connection to other asthma genes is most likely a
causal asthma gene. Chromosomes 2q12 and 17q21 both have
strong GWAS hits for asthma. However, these loci harbor a
number of genes that could potentially explain these hits10,11.
Following the workflow shown in Figure S4 [27], we drew
inference on causal genes underlying asthma GWAS signals on
these two chromosomes (Table 4). Clearly IL1RL1’s subnetwork is
enriched for canonical asthma genes (P=1.8610207) making it the
most likely gene driving the asthma association on 2q12. The
result for 17q21 is less clear, but still points away from ORMDL3,
the gene first suggested as causal by Moffatt et al. [10]. The sub-
network around GSDMA is significantly enriched for canonical
genes (P=0.005) suggesting that GSDMA is the most likely driver
behind the asthma association on 17q21.
Discussion
One of the primary goals of genetic studies is to identify genes
and pathways which contribute to susceptibility to human diseases
and towards this goal many GWA studies have discovered SNPs in
novel genes [1–16]. However, the mechanism by which these
SNPs lead to disease susceptibility cannot be directly inferred from
GWAS. The discovery of eQTLs has been shown to be a powerful
tool in addressing this gap [18–20]. Although eQTL analysis of
readily available tissue types such as peripheral blood leukocytes
and lymphoblastoid cell lines has contributed to the understanding
of how genes modulate risk of respiratory diseases, the discovery of
lung-specific eQTL is probably more revealing in understanding
the pathogenesis of respiratory disease. In this paper, we
determined genetic variation and interrogated gene expression in
a large collection (n = 1,111) of human lung samples to system-
atically characterize the genetic architecture of gene expression in
this tissue. Owing to the large sample size, we discovered over
17,000 eQTLs. These eQTLs are gene variants that directly or
indirectly govern gene expression in the lung and the data set
represents a unique resource which we have made available for the
use of lung researchers.
To illustrate the power of the resource we merged these data
with SNPs known to be strongly associated with asthma and were
able to identify the most likely causal gene variants. Chromosome
17q21 is the most consistent locus associated with asthma
[9,10,29–36]. In the original GWAS study [10], the SNPs
***Moffatt et al. [9] reported that SNPs at the IL1RL1 locus were associated with asthma and the GWAS peak was located at rs3771166. The latter SNP was not a strong
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Figure 2. Lung eQTLs found on chromosome 17q21. (a) The upper panel is a region of chromosome 17q21 from the UCSC browser showing
the genes located in this region. The next panel shows the results from the GABRIEL consortium [9] (each bar represents a SNP and the y-axis shows
2log10 P values for association with asthma). The following three panels show the lung eQTL results for expression levels of ORMDL3 (blue bars),
GSDMB (green bars), and GSDMA (red bars), respectively. The y-axis represents 2log10 P values derived from the meta-analysis of gene expression.
The black horizontal lines are drawn at P= 0.05. (b) Boxplots of lung gene expression levels for GSDMA according to genotype groups for SNPs
rs3859192 and rs7216389 in 1,111 subjects.
doi:10.1371/journal.pgen.1003029.g002
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associated with asthma in the 17q21 susceptibility locus were also
associated with transcript levels of ORMDL3 in lymphoblastoid cell
lines, suggesting that ORDML3 was the causal gene. However,
more refined analysis of the same samples, exploiting data
generated by the 1000 genomes project, suggested that GSDMB,
in close proximity to ORMDL3, could be the causal gene [9].
Another eQTL study performed in white blood cell RNA samples
suggested that many SNPs in the 17q21 regions are associated
with transcript levels of both ORMDL3 and GSDMB [32]. Verlaan
et al. [37] showed that SNPs in the region demonstrate domain-
wide cis-regulatory effects suggesting long-range chromatin inter-
actions and they found allele-specific differences in nucleosome
distribution and binding of the insulator protein CTCF. A recent
study also showed that asthma risk alleles on 17q21 were
associated with increased ORMDL3 and GSDMA gene expression
and elevated IL-17 secretion in cord blood mononuclear cells [38].
To refine the causal gene/variant, we have interrogated our
eQTL results within this locus. Interestingly, the SNPs most
strongly associated with the expression of ORMDL3 are located in
the promoter (rs4794820) and intron 1 (rs12603332) of the
ORMDL3 gene, but the P values are not convincing (most
significant SNP rs4794820 P=1.061027). In addition the SNP
Figure 3. Relative expression of GSDMA and GSDMB. Primary human airway epithelial cells in monolayer culture were analyzed for; (a) the
relative abundance of mRNA for GSDMA and GSDMB (n = 7) and (b) Protein expression of GSDMA and GSDMB by Western blot normalized to
expression of b-tubulin (n = 10). (c) Representative image of GSDMA expression in human conducting airway by immunohistochemistry, which shows
expression of GSDMA in both basal and apical cells within the airway epithelium.
doi:10.1371/journal.pgen.1003029.g003
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rs4794820 is more strongly associated with mRNA expression
levels of GSDMB (P=9.3610212) and GSDMA (P=2.2610246).
Rs4794820 is located between ORMDL3 and GSDMA on 17q21
(see Figure 2a for the location of genes). Considering the
transcription orientation of ORMDL3, GSDMA, and GSDMB,
rs4794820 lies in the promoter of the three genes and is possibly a
pleiotropic regulatory variant or, more likely, in LD with such a
regulatory element. We observed a concordance between SNPs
associated with transcript levels of ORMDL3, GSDMB and GSDMA
(Figure 2a). These genes are likely co-regulated, as proposed
previously [32,37]. However, the most compelling eQTL on
17q21 was observed in the association between the asthma
susceptibility SNP (rs3859192 – p= 1.11212 for association with
asthma) and the level of expression of GSDMA (P=3.556102151,
Figure 2b). In fact, many SNPs on 17q21 were strongly associated
with the expression of GSDMA (Figure 2a). Thus our data
strongly suggest that the SNPs across this whole locus are
associated with asthma because they modulate GSDMA expres-
Figure 4. Q–Q plot for the GABRIEL meta-analysis among eSNPs found in the lung eQTL study. Among all SNPs surveyed by the GABRIEL
meta-analysis, 60,530 were eSNPs in the Lung eQTL study and considered in this Q-Q plot. As is apparent eQTLs were enriched for lower P values
(enrichment P value,2.2E216). Panel (a) is GABRIEL eSNPs plotted against GABRIEL SNPs, panel (b) is eSNPs of canonical asthma genes plotted
against GABRIEL SNPs and panel (c) is eSNPs of canonical asthma genes plotted against GABRIEL eSNPs.
doi:10.1371/journal.pgen.1003029.g004
Figure 5. The meta-analysis Bayesian network with the top 6 KDA genes and their nearest neighbors. KDA genes are in yellow,
canonical genes are in blue, and all other genes are in grey. P values for each of the key driver genes are in Table S3.
doi:10.1371/journal.pgen.1003029.g005
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sion in the lung, clearly showing the value of our lung eQTL
dataset to refine previous GWAS hits for asthma. It should be
noted that correlations between GWAS and eQTL results must be
interpreted with caution. Here we related eQTLs in the lung to
GWAS studies for asthma which is an airway disease but which is
known to involve other tissue types including immune cells. The
genetic control of gene expression is tissue specific. Regulatory
variants for GSDMA identified in the lung may regulate a different
gene(s) in another relevant tissue or cell-type for asthma. More
functional work in multiple tissues and cell-types measuring gene
expression with or without various stimuli will be required to
confirm the causal asthma gene on 17q21.
The case for GSDMA as the susceptibility gene underlying the
17q GWAS signal is supported by biologic plausibility. GSDMA
is a member of the gasdermin family of proteins first identified in
the mouse [39]. They have been reported as being expressed in
the upper gastrointestinal tract and skin where they are involved
in the regulation of apoptosis and act as tumor suppressors [40].
Further support for GSDMA as an asthma susceptibility gene is
our observation that GSDMA is robustly expressed in human
airway epithelium (Figure 3). In addition its network neighbor-
hood is enriched in genes involved in immune responses. We
examined the genes around GSDMA using Bayesian and co-
expression networks, and performed functional annotation of
these genes (Table S4a–S4b). The GSDMA network neighbor-
hood is enriched for a number of immune response pathways,
which are highly relevant to asthma.
By integrating asthma GWAS results with our eSNP and
Bayesian network, we were able to identify a network of 34 genes
that highlights the molecular underpinnings of asthma (Figure 5 and
Table S3). This network of genes is annotated as inflammatory response
by the online tool DAVID [41] with an enrichment score of 3.27
(P=761026). Of particular interest is one Key Driver node, SOCS3
(suppressor of cytokine signaling 3). SOCS3 belongs to the SOCS
family of genes that are cytokine-inducible negative regulators of
cytokine signaling and play an important role in TH2-mediated
allergic responses through control of the balance between TH1 and
TH2 cells. It is implicated in both asthma and atopic dermatitis, as
well as in regulating serum IgE levels [42]. Moriwaki and colleagues
found that down-regulation of Socs3 in ovalbumin sensitized mice
caused attenuation of eosinophilia and airway hyperresponsiveness
generated by ovalbumin challenge [43].
Important discoveries in the field of asthma were made using
eQTL mapping in lymphoblastoid cell lines [10]. In this study,
we used lung tissue to map lung eQTLs, which is likely the most
relevant tissue to study the genetics of lung diseases like asthma.
Ideally one would want to relate SNPs to gene expression and to
disease phenotype using tissue or cells from individuals affected
by the disease of interest [44]. In this study, only a small
percentage of the subjects had self-reported asthma. It should be
noted that eQTL mapping in liver tissues was successful to
identify new susceptibility genes for type 1 diabetes, coronary
artery disease and blood lipid levels [19,20,45]. These discov-
eries were made regardless of the medical condition of patients
from whom the liver tissues were explanted. Similarly, lung
tissue from any source (normal or diseased) is a valid approach
to identify the genetic variants that influence gene expression
irrespective of disease status. The heterogeneous nature of the
tissue we profiled with varying environmental exposures (e.g.
smoking) and disease status (e.g. lung cancer) would not be
expected to generate associations between SNPs and gene
expression but would rather tend to introduce noise into these
relationships.
In summary, the present study reports on a comprehensive set of
lung eQTLs that complement previous large scale studies of eQTLs
in other tissue types [18,19] and which can be used to shed light on
GWAS findings in lung diseases. Using the results of the largest
asthma GWA study as an example we show how the lung tissue
eQTL dataset can be used to identify the most likely causal genes and
pathways. This dataset constitutes an invaluable tool to provide new
insights into the pathogenesis of other lung diseases such as chronic
obstructive pulmonary disease, lung cancer and cystic fibrosis.
Materials and Methods
Ethics statement
All lung tissue samples were obtained in accordance with
Institutional Review Board guidelines at the three sites: Laval
University (Quebec, Canada), University of British-Columbia
(Vancouver, Canada) and Groningen University (Groningen, The
Netherlands). All patients provided written informed consent and
the study was approved by the ethics committees of the Institut
universitaire de cardiologie et de pneumologie de Que´bec and the
UBC-Providence Health Care Research Institute Ethics Board for
Laval and UBC, respectively. The study protocol was consistent
with the Research Code of the University Medical Center
Groningen and Dutch national ethical and professional guidelines
(‘‘Code of conduct; Dutch federation of biomedical scientific
societies’’; http://www.federa.org).
Lung tissues collection
Lung tissue was collected from patients who underwent lung
resectional surgery at the three participating sites; Laval Univer-
sity, University of British Columbia, and University of Groningen.
Lung specimens from the Laval site were taken from the
Respiratory Health Network Tissue Bank of the FRQS (www.
rsr.chus.qc.ca). Subjects’ enrollment and lung tissues processing at
the three sites are described in Text S1.
Genome-wide gene expression and genotyping
Gene expression profiles were obtained using a custom
Affymetrix array (see GEO platform GPL10379) testing 51,627
non-control probesets. DNA samples were genotyped on the
Illumina Human1M-Duo BeadChip array. 409, 363, and 339
patients had both genotyping and gene expression data that passed
standard quality controls (see Text S1) in Laval, Groningen, and
UBC, respectively. These final datasets (total n = 1,111) were used
to discover eQTLs and to identify eSNPs.
Table 4. Driver genes behind the asthma association on
17q21 and 2q12.
Chr Genes x k P=value
17 GSDMA 7 130 0.0049
GSDMB 4 94 0.054
ORMDL3 3 204 0.2208
2 IL18R1 16 381 0.0004
IL18RAP 0 0 1
IL1RL1 19 283 1.88610207
m=Canonical list [27] (119 genes).
x = Canonical genes within the set of genes within 3 edges of QTL gene.
n = Bayesian – Canonical list (7000 genes).
k = Genes within 3 edges of QTL gene.
doi:10.1371/journal.pgen.1003029.t004
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Statistical analysis
The normalized expression data were adjusted for age, gender
and smoking status in a robust linear model to accommodate
potential outliers in expression level (Figure 1). In parallel, we
performed genotype QC to exclude SNPs of low call rate (,0.9)
and deviating from Hardy-Weinberg equilibrium (P,161026).
Genotype imputations were based on the cleaned sets. In the end,
assayed and imputed genotypes were used to identify cis and trans
acting expression quantitative trait loci (eQTLs) following a
method similar to that previously described in Schadt et al. [19].
The strategy for assembling of the asthma candidate gene list
(Table S5) and for constructing Bayesian networks, and co-
expression modules are given in Text S1.
Supporting Information
Figure S1 Distribution of the R2 values for the relationships between
eSNPs and gene expression using a 10% false discovery rate for cis
acting eQTLs (upper panel) and trans acting eQTLs (lower panel).
(PDF)
Figure S2 Workflow to identify key drivers of the lung Bayesian
networks. We filtered the asthma GWAS SNPs down only to those
SNPs that associate with the trait asthma and have a significant
corresponding gene expression pattern in the lung (lung eSNP). The
eSNP filtered genes where used to identify the asthma subnetwork
from the larger Bayesian network from which KDA was performed.
(PDF)
Figure S3 The largest lung expression subnetwork that has the
highest proportion of GABRIEL genes.
(PDF)
Figure S4 Workflow to identify the most likely gene that drives
the GWAS asthma association on chromosomes 2 and 17. The
logic is that a gene that is surrounded by known asthma genes is
more likely to be an asthma gene itself.
(PDF)
Table S1 Mean (Median) of regression r2 in expressional QTLs.
(PDF)
Table S2 (a) cis-eQTLs at 10% FDR. (b) Trans-eQTLs at 10% FDR.
(XLSX)
Table S3 Six Key Driver Analyses (KDA) genes that remains
significant after correction for multiple testing.
(PDF)
Table S4 Biological functions of the Bayesian network sur-
rounding GSDMA.
(PDF)
Table S5 Asthma candidate genes.
(PDF)
Text S1 Supporting Information.
(DOCX)
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